![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Declaration of interest
R. Uger is an employee of and has a leadership role at Trillium Therapeutics Inc. L. Johnson is employed by Trillium Therapeutics Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Reviewer Disclosures
A reviewer on this manuscript has disclosed that they work on CD47 blockers in their lab and their institution has filed for protection for them. All other peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
Additional information
Funding
This manuscript was funded by Trillium Therapeutics Inc.